Key result
PNPLA3 GG genotype shows no association with NAFLD or hepatitis in the Yakut population.
Why the study?
The study was conducted to evaluate the frequency of the I148M polymorphism of the PNPLA3 gene, which is associated with a risk of steatosis and liver fibrosis, in residents of the Republic of Sakha (Yakutia).
Observational (n=3,132)
p-value: p=0.82
The frequency of the mutant G allele of the I148M polymorphism of the PNPLA3 gene is exceptionally high in the Yakut population but does not significantly differ between healthy controls and those with NAFLD or chronic hepatitis.
High GG frequency in Yakuts shows no NAFLD link; leaves open ethnic modifiers of PNPLA3 risk.
Background Single nucleotide polymorphism (SNP) are the most common type of genetic polymorphism. SNP can significantly affect the expression activity of genes and the level of protein production. Researching the role of SNP in the occurrence of diseases is an important and urgent task, as it allows to predict the risk of pathology, its severity and outcome. Purpose of the study: study of the frequency of I148M polymorphism of the PNPLA3 gene in residents of the Republic of Sakha (Yakutia), associated with a high risk of steatosis and liver fibrosis. Methods A total of 3132 peripheral venous blood samples were used for population studies, studies patients with chronic hepatitis B and C, studies patients with NAFLD. Genotyping of DNA samples was carried out by real time-PCR. Reagent kits were used for genotyping I148M polymorphism of the PNPLA3 gene. Results In the present study, it was found that in the Yakut population the carriage of the GG genotype (49%) of the PNPLA3 gene I148M polymorphism predominates. When conducting a comparative frequency analysis, there were no statistically significant differences between the control group and the group with NAFLD patients(p=0,82). A comparative frequency analysis of the distribution of genotypes and alleles of I148M polymorphism of the PNPLA3 gene in the control group and the group of patients with chronic hepatitis B and C showed that we did not reveal significantly significant differences (p = 0.45). Conclusions The frequency of homozygotes for the mutant G allele of the I148M polymorphism of the PNPLA3 gene in the Yakut population significantly exceeds the frequency indicator of the G allele in other world populations.
No takes yet. Share an insight, caveat, or question.
Sleptsovа et al. (2021) conducted an observational in Steatosis, liver fibrosis, NAFLD, chronic hepatitis B and C (n=3,132). I148M polymorphism of the PNPLA3 gene vs. Control group was evaluated on Frequency of I148M polymorphism of the PNPLA3 gene (GG genotype) (p=0.82). The GG genotype of the PNPLA3 gene I148M polymorphism was found in 49% of the Yakut population, with no significant differences between controls and patients with NAFLD (p=0.82) or hepatitis (p=0.45).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: